The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Multiple sclerosis prevalence in the United States commercially insured population
Open accessAbstract
OBJECTIVE: To estimate the US commercially insured multiple sclerosis (MS) annual prevalence from 2008 to 2012. METHODS: The study was a retrospective analysis using PharMetrics Plus, a nationwide claims database for over 42 million covered US representative lives. Annual point prevalence required insurance eligibility during an entire year. Our primary annual MS identification algorithm required 2 inpatient claims coded ICD-9 340 or 3 outpatient claims coded ICD-9 340 or 1 MS-indicated disease-modifying therapy claim. Age-adjusted annual prevalence estimates were extrapolated to the US population using US Census data. RESULTS: The 2012 MS prevalence was 149.2 per 100,000 individuals (95% confidence interval 147.6-150.9). Prevalence was consistent over 2008-2012. Female participants were 3.13 times more likely to have MS. The highest prevalence was in participants aged 45-49 years (303.5 per 100,000 individuals [295.6-311.5]). The East Census region recorded the highest prevalence (192.1 [188.2-196.0]); the West Census region recorded the lowest prevalence (110.7 [105.5-116.0]). The US annual 2012 MS extrapolated population was 403,630 (387,445-419,833). CONCLUSIONS: MS prevalence rates from a representative commercially insured database were higher than or consistent with prior US estimates. For further accuracy improvement of US prevalence estimates, results should be confirmed after validation of MS identification algorithms, and should be expanded to other US populations, including the government-insured and the uninsured.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning
Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., & Unverzagt, F. (1991) · Neurology · doi:10.1212/wnl.41.5.692 · Cited by 890
Multiple Sclerosis: Pathogenesis and Treatment
Loma, I., & Heyman, R. (2011) · Current Neuropharmacology · doi:10.2174/157015911796557911 · Cited by 350
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
Marrie, R. A., Yu, N., Blanchard, J., Leung, S., & Elliott, L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cf6ec0 · Cited by 307
Quality of life in multiple sclerosis: Measuring the disease effects more broadly
Nortvedt, M. W., Riise, T., Myhr, K., & Nyland, H. I. (1999) · Neurology · doi:10.1212/wnl.53.5.1098 · Cited by 307
Revised estimate of the prevalence of multiple sclerosis in the united states
Anderson, D. W., Ellenberg, J. H., Leventhal, C. M., Reingold, S. C., Rodriguez, M., & Silberberg, D. H. (1992) · Annals of Neurology · doi:10.1002/ana.410310317 · Cited by 305
Mackenzie, I. S., Morant, S. V., Bloomfield, G. A., MacDonald, T. M., & O'Riordan, J. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305450 · Cited by 300
Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution
Kurtzke, J. F., Beebe, G. W., & Norman, J. E. (1979) · Neurology · doi:10.1212/wnl.29.9_part_1.1228 · Cited by 275
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000
Mayr, W. T., Pittock, S. J., McClelland, R. L., Jorgensen, N. W., Noseworthy, J. H., & Rodriguez, M. (2003) · Neurology · doi:10.1212/01.wnl.0000094316.90240.eb · Cited by 243
The cost burden of multiple sclerosis in the United States: a systematic review of the literature
Adelman, G., Rane, S. G., & Villa, K. F. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.778268 · Cited by 205
Prevalence estimates for MS in the United States and evidence of an increasing trend for women
Noonan, C. W., Kathman, S. J., & White, M. C. (2002) · Neurology · doi:10.1212/wnl.58.1.136 · Cited by 198
Cited by
The prevalence of MS in the United States: A population-based estimate using health claims data
Wallin, M. T., Culpepper, W. J., Campbell, J. D., Nelson, L. M., Langer-Gould, A., Marrie, R. A., Cutter, G. R., Kaye, W. E., Wagner, L., Tremlett, H., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007035 · Cited by 1,098
Self-citationLo, J., Chan, L., & Flynn, S. (2021) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2020.04.001 · Cited by 403
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Epidemiology and treatment of multiple sclerosis in elderly populations
Vaughn, C. B., Jakimovski, D., Kavak, K. S., Ramanathan, M., Benedict, R. H. B., Zivadinov, R., & Weinstock-Guttman, B. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0183-3 · Cited by 306
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Metadata
- Authors
- Dilokthornsakul, P., Valuck, R. J., Nair, K. V., Corboy, J. R., Allen, R. R., & Campbell, J. D.
- Venue
- Neurology
- Published
- 2016-03-15
- Volume
- 86
- Issue
- 11
- Pages
- 1014-1021
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2288073912
- Cited by
- 273
- References
- 23
- FWCI
- 27.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiple sclerosis prevalence in the United States commercially insured population. https://app.cochat.ai/papers/10.1212/wnl.0000000000002469
- The paper
- Dilokthornsakul, P., Valuck, R. J., Nair, K. V., Corboy, J. R., Allen, R. R., & Campbell, J. D. (2016). Multiple sclerosis prevalence in the United States commercially insured population. Neurology. https://doi.org/10.1212/wnl.0000000000002469
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.